Home - Products - Others - Other Targets - Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (33-40)

Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (33-40)

CAS No. ———

Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (33-40)( ——— )

Catalog No. M40766 CAS No. ———

Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (33-40)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (33-40)
  • Note
    Research use only, not for human use.
  • Brief Description
    Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (33-40)
  • Description
    Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (33-40)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    1203.52
  • Molecular Formula
    C51H92N15O14S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2,3,4,5-Tetracaffeoy...

    2,3,4,5-Tetracaffeoyl-D-Glucaric acid is a compound isolated from Inula japonica that inhibits fat accumulation and reduces body fat and can be used in the study of obesity.

  • Basiliximab

    Basiliximab (CHI 621) is a chimeric mouse/human IgG1 monoclonal recombinant antibody targeting the interleukin-2 receptor, demonstrating potent immunosuppressive activity for use in kidney transplantation studies.

  • AP20187

    AP20187 (B/B Homodimerizer) is a cell-permeable ligand used to dimerize FK506-binding protein (FKBP) fusion proteins. And it initiate biological signaling cascades and gene expression or disrupt protein-protein interactions.